Advanced Biomedical Technologies, Inc. announced earnings results for the full year ended October 31, 2020. For the full year, the company announced sales was USD 123,587 compared to USD 11,657 a year ago. Operating loss was USD 446,624 compared to USD 604,738 a year ago. Net loss was USD 672,000 compared to USD 948,820 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.